Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
10x Genomics Inc (TXG)
NASDAQ:TXG
Holding TXG?
Track your performance easily
10x Genomics (TXG) Ownership Overview
2.08% Insiders
27.76% Mutual Funds
37.86% Other Institutional Investors
22.44% ETFs
9.86% Public Companies and Individual Investors
The ownership structure of 10x Genomics (TXG) stock is a mix of institutional, retail, and individual investors. Approximately 88.06% of the company’s stock is owned by Institutional Investors, 2.08% is owned by Insiders, and 9.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 25, 2024 | Benjamin J. Hindson President And Chief Scientific Officer,director | xxxxxxxxxxxxx | $79440 |
| Nov 25, 2024 | Serge Saxonov Ceo,director | xxxxxxxxxxxxx | $91560 |
| Aug 26, 2024 | Benjamin J. Hindson President And Chief Scientific Officer,director | xxxxxxxxxxxxx | $97985 |
| Aug 26, 2024 | Serge Saxonov Ceo,director | xxxxxxxxxxxxx | $151987 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $283198 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $6670132 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $34071932 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $242742790 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,098,043 | Institution | 10.37% | 176,458,884 | |
| 10,750,345 | Institution | 10.05% | 170,930,486 | |
| 9,239,934 | Institution | 8.64% | 146,914,951 | |
| 8,782,707 | Institution | 8.21% | 139,645,041 | |
| 4,109,821 | Institution | 3.84% | 65,346,154 | |
| 2,884,661 | Institution | 2.70% | 45,866,110 | |
| 2,367,912 | Institution | 2.21% | 37,649,801 | |
| 1,611,400 | Institution | 1.51% | 25,621,260 | |
| 1,544,672 | Institution | 1.44% | 24,560,285 | |
| 1,508,943 | Institution | 1.41% | 23,992,194 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,782,707 | Institution | 8.21% | 139,645,041 | |
| 4,109,821 | Institution | 3.84% | 65,346,154 | |
| 1,611,400 | Institution | 1.51% | 25,621,260 | |
| 1,544,672 | Institution | 1.44% | 24,560,285 | |
| 1,366,395 | Institution | 1.28% | 21,725,681 | |
| 1,152,067 | Institution | 1.08% | 18,317,865 | |
| 1,078,448 | Institution | 1.01% | 17,147,323 | |
| 961,565 | Institution | 0.90% | 15,288,884 | |
| 951,792 | Institution | 0.89% | 15,133,493 | |
| 913,270 | Institution | 0.85% | 14,520,993 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,200,764 | Institution | 7.66% | 130,392,148 | |
| 3,236,223 | Institution | 3.02% | 51,876,655 | |
| 2,873,068 | Institution | 2.69% | 45,681,781 | |
| 2,532,917 | Institution | 2.37% | 40,602,660 | |
| 1,600,509 | Institution | 1.50% | 25,656,159 | |
| 1,396,603 | Institution | 1.31% | 22,387,546 | |
| 688,858 | Institution | 0.64% | 10,952,842 | |
| 517,825 | Institution | 0.48% | 8,015,931 | |
| 395,752 | Institution | 0.37% | 6,292,457 | |
| 346,595 | Institution | 0.32% | 5,510,861 |
FAQ
Who Owns 10x Genomics Inc (TXG)?
According to the latest TipRanks data, approximately 37.86% of the company's stock is held by institutional investors, 2.08% is held by insiders, and 9.86% is held by retail investors.
What percentage of 10x Genomics Inc (TXG) stock is held by institutional investors?
According to the latest TipRanks data, approximately 37.86% of 10x Genomics Inc (TXG) stock is held by institutional investors.
What percentage of 10x Genomics Inc (TXG) stock is held by retail investors?
According to the latest TipRanks data, approximately 9.86% of 10x Genomics Inc (TXG) stock is held by retail investors.
Who owns the most shares of 10x Genomics Inc (TXG)?
ARK owns the most shares of 10x Genomics Inc (TXG).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.